CD59 (YTH53.1) Antibody sc-59095 from Santa Cruz Biotechnology, Inc.

Product Specs
ItemCD59 (YTH53.1) Antibody
CompanySanta Cruz Biotechnology, Inc.
Price $316.00Supplier Page View Company Product Page
Catalog Numbersc-59095
NCBI Gene Aliases16.3A5, EJ30, G344, MIN3, p18-20, MIRL, HRF-20, EJ16, 1F5, MIC11, Cd59, MACIF, MAC-IP, MSK21, MEM43, EL32, MIN1, MIN2, HRF20
Antibody TypePrimary Antibodies
Quantity200 µg/ml
CloneYTH53.1
ApplicationsWB, IP, IF, FCM
Reactivitymouse, rat, human
ClonalityMonoclonal
Hostrat
Conjugate/TagUnconjugated
FormatPurified
NCBI Full Gene NameCD59 molecule (CD59 blood group), CD59a antigen
IsotypeIgG2b
TargetCD59

Add to Compare List

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) Tafazzin deficiency in mouse mesenchymal stem cells promote reprogramming of activated B lymphocytes toward immunosuppressive phenotypesFASEB journal : official publication of the Federation of American Societies for Experimental BiologyAugust 1, 2022Zegallai HM, Abu-El-Rub E, Olayinka-Adefemi F, Cole LK, Sparagna GC, Marshall AJ, Hatch GM.(Catalog no. sc‐137012), CTLA‐4 (Catalog no. sc‐376016), IL‐10 (Catalog no. sc‐365858), CD59 (Catalog no. sc‐59095), Tafazzin (Catalog no. sc‐365810), and β‐Actin (Catalog no. sc‐47 778) from Santa Cruz Biotechnology

(2) Tafazzin deficiency in mouse mesenchymal stem cells potentiates their immunosuppression and impairs activated B lymphocyte immune functionbioRxiv : the preprint server for biologySeptember 8, 2021Zegallai HM, Abu-El-Rub E, Olayinka-Adefemi F, Cole LK, Sparagna GC, Marshall AJ, Hatch GM.

(3) Complement factor H protects tumor cell-derived exosomes from complement-dependent lysis and phagocytosisPloS oneJanuary 1, 2021Bushey RT, Gottlin EB, Campa MJ, Patz EF Jr.

(4) CD55 upregulation in astrocytes by statins as potential therapy for AQP4-IgG seropositive neuromyelitis opticaJournal of neuroinflammationMarch 9, 2019Tradtrantip L, Duan T, Yeaman MR, Verkman AS.

(5) Complement Regulation and Immune Evasion by Hepatitis C VirusMethods in molecular biology (Clifton, N.J.)January 1, 2019Kwon YC, Ray R.

(6) Effect of membrane-bound complement regulatory proteins on tumor cell sensitivity to complement-dependent cytolysis triggered by heterologous expression of the α-gal xenoantigenOncology lettersJune 1, 2018Wang Y, Liao J, Yang YJ, Wang Z, Qin F, Zhu SM, Zheng H, Wang YP.Beijing 4A Biotech Co., Ltd. (Beijing, China). The mAbs against CD55 (cat. no. SC‑59092), CD59 (cat. no. SC‑59095), and β ‑actin (cat. no. SC‑47778) for western blotting were purchased from Santa Cruz Biotechnology, Inc

(7) CD55 and CD59 expression protects HER2-overexpressing breast cancer cells from trastuzumab-induced complement-dependent cytotoxicityOncology lettersSeptember 1, 2017Wang Y, Yang YJ, Wang Z, Liao J, Liu M, Zhong XR, Zheng H, Wang YP.

(8) Enhanced CDC of B cell chronic lymphocytic leukemia cells mediated by rituximab combined with a novel anti-complement factor H antibodyPloS oneJanuary 1, 2017Winkler MT, Bushey RT, Gottlin EB, Campa MJ, Guadalupe ES, Volkheimer AD, Weinberg JB, Patz EF Jr.

(9) Distinct CD55 Isoform Synthesis and Inhibition of Complement-Dependent Cytolysis by Hepatitis C VirusJournal of immunology (Baltimore, Md. : 1950)August 15, 2016Kwon YC, Kim H, Meyer K, Di Bisceglie AM, Ray R.

(10) Membrane-bound complement regulatory proteins are prognostic factors of operable breast cancer treated with adjuvant trastuzumab: a retrospective studyOncology reportsDecember 1, 2014Liu M, Yang YJ, Zheng H, Zhong XR, Wang Y, Wang Z, Wang YG, Wang YP.

(11) CD55 limits sensitivity to complement-dependent cytolysis triggered by heterologous expression of α-gal xenoantigen in colon tumor cellsAmerican journal of physiology. Gastrointestinal and liver physiologyJune 15, 2014Wu Y, Wang Y, Qin F, Wang Z, Wang Y, Yang Y, Zheng H, Wang Y.

(12) P-selectin glycoprotein ligand-1 as a potential target for humoral immunotherapy of multiple myelomaCurrent cancer drug targetsAugust 1, 2009Tripodo C, Florena AM, Macor P, Di Bernardo A, Porcasi R, Guarnotta C, Ingrao S, Zerilli M, Secco E, Todaro M, et al.

Be the First to Write a Review!

CD59 (YTH53.1) Antibody

CD59 (YTH53.1) Antibody from Santa Cruz Biotechnology, Inc.

Description

Santa Cruz Biotechnology, Inc.

Citations (12)

Reviews

CD59 (YTH53.1) Antibody from Santa Cruz Biotechnology, Inc.

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map